Eli Lilly and Company
A leader within Eli Lilly’s Diabetes, Obesity and Complications Therapeutic Area (DOCTA) responsible for guiding heart failure drug discovery and development from target identification through IND-enabling studies. The role provides scientific vision for preclinical programs, leads a team of scientists, and partners across functions to advance therapeutic candidates toward clinical development.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Associate Director of Pharmacology
ampersandpeople
Associate Director
Regeneron Pharmaceuticals
Head of Discovery & Translation
8a7883d06e8c9499016e8fd15a5d0203
Sr. Director, Pharmacology
Cellarity
Sr. Director, Pharmacology
Flagship Pioneering, Inc.
Preclinical Programme Leader, Cardiovascular & Metabolic Diseases
ASTARPRD